|
Old
is not gold?
There has been little focus on the medication needs of elderly
patients, inspite of the many differences between geriatric
and general medicine. Suja Nair finds out why
Aurobindo
expands agreement with Pfizer
Aurobindo Pharma has expanded its partnership further by executing
licensing and supply agreements for several solid dosage and
sterile products with Pfizer
Light
at the end of the tunnel
Express Pharma presents some guestimates of the Indian pharmaceutical
sector's performance in the next few quarters, based on industry
reports
Strengthening
position
After getting Japan accreditation for Ibuprofen, IOL Chemicals
and Pharmaceuticals (IOLCP) has plans to enlarge its domestic
as well as international business. Varinder Gupta, Chairman
and Managing Director, (IOLCP) shares more details with Usha
Sharma
Intas
Biopharma to market NSCLC drug in India
Intas Biopharmaceuticals oncology drug marketing company is
launching Pemetrexed in India under the brand name of Pemmet
Wockhardt
to market anti ulcer syrup 'ranitidine' in US
Drug maker Pharmaceutical and biotechnology company, Wockhardt
has obtained final marketing approval for US from US Food
and Drug Administration (FDA) for ranitidine hydrochloride
Jubilant
gets Canadian nod for sestamibi
Jubilant Organosys's Canadian subsidiary, Draxis obtained
Health Canada approval for the generic sestamibi. Sestambil
Injection is used in the treatment of myocardial infarction,
ischemic heart disease and coronary artery disease
Ranbaxy
on US FDA's AIP listing
Ranbaxy has received a letter and information indicating that
all pending and approved Abbreviated New Drug Applications
(ANDAs) from Ranbaxy's Paonta Sahib facility have been added
to a list maintained under a policy entitled 'Application
Integrity Policy' or 'AIP'
Aurobindo
gets Australian approval for hypertension drug
Aurobindo Pharma's Australian subsidiary Aurobindo Pharma
Australia received first product approval from Therapeutic
Goods Administration (TGA), Australia for the registration
of Auro-Lisinopril 5, Auro-Lisinopril 10 and Lisinopril (dihydrate)
tablets
Piramal
Healthcare finalises deal with Minrad
Piramal Healthcare leading pharmaceutical and healthcare company
has completed its previously announced acquisition of US-based
Minrad International (Minrad)
Merck
to buy Schering-Plough
Merck & Co set to buy US-based pharmaceutical company
Schering-Plough for $41.1 billion in cash and stock to get
a larger experimental pipeline and products unhindered by
imminent patent losses
Bharat
Biotech introduces pentavalent combination vaccine in India
Bharat Biotech International (BBIL), a leading producer of
vaccines and biotherapeutics in India has launched Comvac5
in India
Ozone
Ayurvedics focusing on brand awareness; launches Nomarks variants
The Delhi-based leading over the counter (OTC) company Ozone
Ayurvedics, a division of Ozone Group is strengthening its
marketing presence in the domestic market with its existing
resources
Event
Brief
German
technology for chemical and pharmaceutical industry
Chemtech and Pharma World Expo 2009, India's international
exhibition and conference concluded at Bombay Exhibition Centre,
Mumbai. Exhibitors from all across the world were present
at the exhibition
DIA
holds 3rd annual conference in Mumbai
Drug Information Association (DIA), the premier, multidisciplinary,
non-profit association has recently concluded its third annual
conference on 'Drug Discovery and Clinical Development in
Mumbai Scientific, Regulatory and Social Frontiers' in Mumbai
on February 25-27, 2009
|
